Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safinamide Switch in Parkinson's Disease
NCT03843944Phase 4Completed
- Sponsor
- Fondazione San Raffaele Monte Tabor
- Start
- May 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of safinamide in Parkinson's disease (PD), sponsored by Fondazione San Raffaele Monte Tabor. Started May 2018; status: completed.
02
Drugs
safinamide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03843944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03843944.